Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory T-Cell Therapy for Graft-versus-host Disease.
Heinrichs J, Bastian D, Veerapathran A, Anasetti C, Betts B, Yu XZ. Heinrichs J, et al. Among authors: betts b. J Immunol Res Ther. 2016;1(1):1-14. Epub 2016 Apr 28. J Immunol Res Ther. 2016. PMID: 27722210 Free PMC article.
Outcomes of human leukocyte antigen-matched related donor and haploidentical allogeneic hematopoietic cell transplantation recipients by immune profiles of recipients and donors.
Herr MM, Balderman SR, Wallace PK, Zhang Y, Tario JD Jr, Buxbaum NP, Holtan S, Ross M, McCarthy PL, Betts B, Maslak P, Hahn TE. Herr MM, et al. Among authors: betts b. Transplant Cell Ther. 2024 May 25:S2666-6367(24)00428-7. doi: 10.1016/j.jtct.2024.05.018. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38801976
Amphiregulin, ST2,and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD.
Etra AM, El Jurdi N, Katsivelos N, Kwon D, Gergoudis SC, Morales G, Spyrou N, Kowalyk S, Aguayo-Hiraldo P, Akahoshi Y, Ayuk FA, Baez J, Betts BC, Chanswangphuwana C, Chen YB, Choe HK, DeFilipp Z, Gleich S, Hexner EO, Hogan WJ, Holler E Prof Dr med, Kitko CL, Kraus S, Al Malki MM, MacMillan ML, Pawarode A, Quagliarella F, Qayed M, Reshef R, Schechter-Finkelstein T, Vasova I, Weisdorf DJ, Wölfl M, Young R, Nakamura R, Ferrara JLM, Levine JE, Holtan SG. Etra AM, et al. Among authors: betts bc. Blood Adv. 2024 Apr 19:bloodadvances.2023011049. doi: 10.1182/bloodadvances.2023011049. Online ahead of print. Blood Adv. 2024. PMID: 38640195
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Boucher JC, Shrestha B, Vishwasrao P, Leick M, Cervantes EV, Ghafoor T, Reid K, Spitler K, Yu B, Betts BC, Guevara-Patino JA, Maus MV, Davila ML. Boucher JC, et al. Among authors: betts bc. Mol Ther Oncolytics. 2023 Nov 20;31:100751. doi: 10.1016/j.omto.2023.100751. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38075241 Free PMC article.
Amphiregulin as a biomarker for monitoring lifethreatening acute graft-versus-host disease: secondary analysis of two prospective clinical trials.
Holtan SG, El Jurdi N, Rashidi A, Betts BC, Demorest C, Galvin JP, MacMillan ML, Weisdorf DJ, Panoskaltsis-Mortari A, Pratta MA. Holtan SG, et al. Among authors: betts bc. Haematologica. 2024 May 1;109(5):1557-1561. doi: 10.3324/haematol.2023.283215. Haematologica. 2024. PMID: 37706330 Free PMC article. No abstract available.
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Jurdi NE, Hoover A, O'Leary D, Cao Q, Gupta A, Ebens C, Maakaron JE, Betts BC, Rashidi A, Juckett MB, Lund T, Bachanova V, MacMillan ML, Miller JS, Orchard PJ, Wagner JE, Vercellotti G, Weisdorf DJ, Dusenbery K, Terezakis S, Holtan SG. Jurdi NE, et al. Among authors: betts bc. Transplant Cell Ther. 2023 Sep;29(9):576.e1-576.e5. doi: 10.1016/j.jtct.2023.06.008. Epub 2023 Jun 11. Transplant Cell Ther. 2023. PMID: 37311510 Clinical Trial.
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease.
Holtan SG, Hoeschen A, Cao Q, Ustun C, Betts BC, Jurdi NE, Maakaron J, Rashidi A, Miller JS, Wagner JE, Blazar BR, Jacobson PA, Panoskaltsis-Mortari A, Weisdorf DJ, MacMillan ML. Holtan SG, et al. Among authors: betts bc. Transplant Cell Ther. 2023 Aug;29(8):509.e1-509.e8. doi: 10.1016/j.jtct.2023.05.021. Epub 2023 Jun 4. Transplant Cell Ther. 2023. PMID: 37279855 Free PMC article. Clinical Trial.
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate.
El Jurdi N, Hoover A, O'Leary D, Cao Q, Gupta A, Ebens C, Maakaron J, Betts BC, Rashidi A, Juckett M, Lund T, Bachanova V, MacMillan M, Miller J, Orchard P, Wagner J, Vercellotti G, Weisdorf D, Dusenbery K, Terezakis S, Holtan S. El Jurdi N, et al. Among authors: betts bc. medRxiv [Preprint]. 2023 Mar 29:2023.03.24.23287521. doi: 10.1101/2023.03.24.23287521. medRxiv. 2023. PMID: 37034603 Free PMC article. Preprint.
117 results